Weight Regain Post Bariatric Surgery: Clinical Trials

6 trials for Weight Regain Post Bariatric Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 withdrawn. 3 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Completed 1
Phase 41Withdrawn 1

Follow Weight Regain Post Bariatric Surgery: new trials by email Literature Review of Weight Regain Post Bariatric Surgery trials Research Report on Weight Regain Post Bariatric Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Time-Restricted Eating After Bariatric Surgery
Time-Restricted Eating (16:8) - Obesity & Overweight, Bariatric Surgery
Not applicableRecruitingMedipol University402025-07-122026-06-29
Interventions for Weight Regain After Bariatric Surgery
Diet, Ketogenic diet, Fasting - Obese Patients With Bariatric Surgery, Obese Patients (BMI ≥ 30 kg/m²)
Not applicableCompletedMedipol University432025-05-122025-08-01
Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric Surgery
Very Low Calorie Diet - Weight Regain Post Bariatric Surgery, Obesity (Disorder)
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven622025-01-202025-03-21
Disordered Eating and Recurrent Weight Gain After MBS
Observational assessment - Obesity & Overweight, Bariatric Surgery
Active not recruitingMedipol University492025-01-022026-02-25
Correlation of Weight Loss With Residual Gastric Volume and Shape on Computerized Tomography in Patients Undergoing Sleeve Gastrectomy
Weight Regain Post Bariatric Surgery
CompletedHelwan University202024-07-072025-03-19
Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery
Naltrexone HCl/Bupropion HCl Placebo, Naltrexone HCl/Bupropion HCl - Weight Regain Post Bariatric Surgery
Phase 4WithdrawnTakeda2016-02-012016-04-08

Narrower conditions

Obesity (3)  ·  Intermittent Fasting (2)  ·  Overweight (2)  ·  Emotional Eating (1)  ·  Feeding and Eating Disorders (1)

Broader conditions

Behavior (3)  ·  Body Weight (3)  ·  Feeding Behavior (3)  ·  Nutrition Disorders (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Overnutrition (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Fasting (2)  ·  Mental Disorders (1)  ·  Overweight (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Angptl4 protein, mouse (1)  ·  Control Groups (1)  ·  Diet (1)  ·  Diet, Ketogenic (1)

Sponsors

Medipol University (3)  ·  Helwan University (1)  ·  Takeda (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Turkey (Türkiye) (3)  ·  Belgium (1)  ·  Egypt (1)  ·  United States (1)